Physical Activity Through Health Technology in Axial Spondyloarthritis
Part of paid clinical trials in Seattle, Washington.
- Sponsor
- University of Washington
- Study ID
- NCT07642622
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Physical activity program intervention — OTHERPatients complete home exercise sessions given via the ExerciseRx app over 20-30 minutes 4 times per week for 12 weeks and receive daily step count goals. Patients also receive a FitBit to wear continuously throughout the study, and are given access to view their step counts via the ExerciseRx app, and receive an educational handout with exercises for axial spondyloarthritis.
- Usual Care Group — OTHERPatients receive recommendations from their physicians to continue their usual physical activity as tolerated, receive a FitBit to wear continuously throughout the study, with the ExerciseRx app locked to the baseline home screen, and receive an educational handout with exercises for axial spondyloarthritis.
Study Details
The purpose of this study is to find out whether a mobile app called the ExerciseRx app is a practical and helpful way for people with axial spondyloarthritis (axSpA) to receive exercise recommendations as part of their regular rheumatology care. Researchers want to learn: Whether people with axSpA find the ExerciseRx app easy to use and helpful for supporting regular exercise. Whether using the ExerciseRx app leads to improvements in symptoms, physical function, and disease activity compared with usual care. Participants assigned to the ExerciseRx group will use the app to complete guided exercises for 20-30 minutes, four times per week. They will also receive personalized weekly step-count goals to help increase their physical activity. Researchers will compare outcomes between participants using the app and those receiving usual care.
Key Dates
- Start date
- Jun 30, 2026
- Status verified
- Jun 2026
- Primary completion
- Apr 30, 2027
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: ExerciseRx appthe ExerciseRx app with personalized exercise recommendations, an educational handout, Fitbit-guided step goals, and physical therapy referral
- Active Comparator: Usual careAn educational handout, Fitbit monitoring without step goals, and physical therapy referral
Primary Outcome Measure
Average minutes of physical activity/exercise during the week and % of participants with adherence to 60% or higher of the recommended exercises [ Time Frame: Week 0 (baseline), 6 and 12 ]
Central Contacts
- Joy Chan206-744-3626
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Harborview Medical Center | Seattle | Washington | 98104 | Rachael Stovall, MD, MAS (PRINCIPAL_INVESTIGATOR) |
| University of Washington | Seattle | Washington | 98195 |
Find similar trials in Seattle, WA
Related Studies
- A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in AdultsPHASE1 · Recruiting · UCB Biopharma SRL · Peoria, Arizona
- A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)PHASE1 · Recruiting · UCB Biopharma SRL · Santa Monica, California